At a glance
- Originator Agouron Pharmaceuticals
- Class
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 21 Sep 2006 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 12 Jul 2000 Profile reviewed but no significant changes made
- 22 Jun 2000 Warner-Lambert has merged with Pfizer